Semaglutide should be a first-line treatment option for adults with diabetic chronic kidney disease and albuminuria, say renal specialists. It follows a landmark Australian-led trial,…
Last month, thousands of endocrinologists and academics attended the American Diabetes Association’s 84th Scientific Sessions in Orlando, Florida. Among those in attendance was Melbourne endocrinologist…
The annual meeting of the American Diabetes Association was held in Orlando, Florida, last month. The conference — one of the biggest events in the…
Patients with diabetes should have access to longer subsidised appointments with allied health professionals and greater access to GLP-1 receptor agonists, a parliamentary inquiry has…
Semaglutide is associated with non-arteritic anterior ischaemic optic neuropathy among patients with type 2 diabetes and those with overweight or obesity, according to a US…
Type 2 diabetes drug tirzepatide has been shown to be effective in treating moderate to severe sleep apnoea in a worldwide clinical trial. US researchers…
New safety warnings about the risk of ileus have been added to all GLP-1 receptor agonists following a TGA investigation into local reports of the…
Pregnant women with type 2 diabetes can safely use metformin in the first trimester, according to US epidemiologists who report no increased risk for congenital…
Patients taking GLP-1 receptor agonists within four weeks of anaesthesia for non-endoscopic procedures should be considered non-fasted, according to new guidance. Doctors are also advised…
Bariatric surgery significantly decreases the conversion from prediabetes to type 2 diabetes, according to a study presented at the annual meeting of the American Society…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
